Literature DB >> 23164361

Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury.

George E Havelka1, Edward S Moreira, Monica P Rodriguez, Nick D Tsihlis, Zheng Wang, Janet Martínez, Joseph A Hrabie, Larry K Kiefer, Melina R Kibbe.   

Abstract

BACKGROUND: Neointimal hyperplasia limits the longevity of vascular interventions. Nitric oxide (NO) is well known to inhibit neointimal hyperplasia. However, delivery of NO to the vasculature is challenging. Our study aims to evaluate the efficacy of delivering NO to the site of injury using a permeable balloon catheter. Our hypothesis is that ultra-short duration NO delivery using a permeable balloon catheter will inhibit neointimal hyperplasia.
MATERIALS AND METHODS: Ten-week-old male Sprague-Dawley rats underwent carotid artery balloon injury. Groups included: (1) control, (2) injury, (3) injury + periadventitial NO, and (4) injury + endoluminal NO via permeable balloon catheter. The catheter was inflated to 5 atm pressure for 5 min. Arteries were harvested 2 wk following injury. Morphometric assessment for neointimal hyperplasia and immunohistochemical staining for inflammatory markers were performed.
RESULTS: Injury increased neointimal hyperplasia compared with control (intima/media area [I/M] ratio 1.07 versus 0.11, respectively, P < 0.001). Periadventitial delivery of NO reduced the I/M area ratio compared with injury alone (55% decrease, P < 0.001). Endoluminal delivery of NO also reduced the I/M area ratio compared with injury alone (65% decrease; P < 0.001). Both endoluminal and periadventitial NO affected the I/M ratio by reducing the intimal area (64% and 46%, respectively, P < 0.001) whereas neither affected the medial area. Periadventitial NO delivery increased lumen area (P < 0.05), whereas endoluminal NO delivery increased circumference (P < 0.05). Periadventitial NO delivery inhibited macrophage intimal infiltration compared with injury alone (P < 0.05).
CONCLUSIONS: These data demonstrate that short-duration endoluminal NO delivery via permeable balloon catheters inhibits neointimal hyperplasia following arterial interventions. Endoluminal delivery of NO could become a focus for future clinical interventions. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23164361      PMCID: PMC3578007          DOI: 10.1016/j.jss.2012.10.048

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  34 in total

1.  Perivascular inflammation after balloon angioplasty of porcine coronary arteries.

Authors:  E Okamoto; T Couse; H De Leon; J Vinten-Johansen; R B Goodman; N A Scott; J N Wilcox
Journal:  Circulation       Date:  2001-10-30       Impact factor: 29.690

2.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

3.  Twenty-year survival after coronary artery surgery: an institutional perspective from Emory University.

Authors:  William S Weintraub; Stephen D Clements; L Van-Thomas Crisco; Robert A Guyton; Joseph M Craver; Ellis L Jones; Charles R Hatcher
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

4.  Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries.

Authors:  G Li; S J Chen; S Oparil; Y F Chen; J A Thompson
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

5.  Mechanisms of stenosis after arterial injury.

Authors:  A W Clowes; M A Reidy; M M Clowes
Journal:  Lab Invest       Date:  1983-08       Impact factor: 5.662

6.  No effect of highly dosed nitric oxide donor molsidomine on the angiographic restenosis rate after percutaneous coronary angioplasty: a randomized, placebo controlled, double-blind trial.

Authors:  Jochen Wöhrle; Martin Höher; Thorsten Nusser; Vinzenz Hombach; Matthias Kochs
Journal:  Can J Cardiol       Date:  2003-04       Impact factor: 5.223

Review 7.  Bone marrow-derived vascular cells in response to injury.

Authors:  Koutaro Yokote; Ayako Take; Chiaki Nakaseko; Kazuki Kobayashi; Masaki Fujimoto; Harukiyo Kawamura; Yoshiro Maezawa; Miki Nishimura; Seijiro Mori; Yasushi Saito
Journal:  J Atheroscler Thromb       Date:  2003       Impact factor: 4.928

8.  Nitric oxide-releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge grafts.

Authors:  Paul S Fleser; Vijay K Nuthakki; Lauren E Malinzak; Rose E Callahan; Marilyn L Seymour; Melissa M Reynolds; Scott I Merz; Mark E Meyerhoff; Phillip J Bendick; Gerald B Zelenock; Charles J Shanley
Journal:  J Vasc Surg       Date:  2004-10       Impact factor: 4.268

9.  Efficacy of local molsidomine delivery from a hydrogel-coated angioplasty balloon catheter in the atherosclerotic porcine model.

Authors:  Pierre H Rolland; Choukri Mekkaoui; Maria Palassi; Alain Friggi; Guy Moulin; Philippe Piquet; Jean-Michel Bartoli
Journal:  Cardiovasc Intervent Radiol       Date:  2002-12-20       Impact factor: 2.740

10.  Local infusion of the nitric oxide donor Sin-1 after angioplasty. Effects on intimal hyperplasia in porcine coronary arteries.

Authors:  J Harnek; E Zoucas; R Sjuve; A Arner; E Ekblad; H Schou; V Perez de Sá; U Stenram
Journal:  Acta Radiol       Date:  2003-07       Impact factor: 1.701

View more
  8 in total

1.  Long-term effect of PROLI/NO on cellular proliferation and phenotype after arterial injury.

Authors:  Edward S M Bahnson; Ashley K Vavra; Megan E Flynn; Janet M Vercammen; Qun Jiang; Amanda R Schwartz; Melina R Kibbe
Journal:  Free Radic Biol Med       Date:  2015-11-26       Impact factor: 7.376

2.  Nitric oxide affects UbcH10 levels differently in type 1 and type 2 diabetic rats.

Authors:  Monica P Rodriguez; Nick D Tsihlis; Zachary M Emond; Zheng Wang; Vinit N Varu; Qun Jiang; Janet M Vercammen; Melina R Kibbe
Journal:  J Surg Res       Date:  2015-02-13       Impact factor: 2.192

3.  Nitric oxide inhibits neointimal hyperplasia following vascular injury via differential, cell-specific modulation of SOD-1 in the arterial wall.

Authors:  Edward S M Bahnson; Nathaniel Koo; Nadiezhda Cantu-Medellin; Aaron Y Tsui; George E Havelka; Janet M Vercammen; Qun Jiang; Eric E Kelley; Melina R Kibbe
Journal:  Nitric Oxide       Date:  2014-11-07       Impact factor: 4.427

4.  Nitric oxide releasing nanomatrix gel treatment inhibits venous intimal hyperplasia and improves vascular remodeling in a rodent arteriovenous fistula.

Authors:  Maheshika Somarathna; Patrick Tj Hwang; Reid C Millican; Grant C Alexander; Tatyana Isayeva-Waldrop; Jennifer A Sherwood; Brigitta C Brott; Isabelle Falzon; Hannah Northrup; Yan-Ting Shiu; Chris J Stubben; John Totenhagen; Ho-Wook Jun; Timmy Lee
Journal:  Biomaterials       Date:  2021-11-18       Impact factor: 15.304

5.  Periadventitial adipose tissue modulates the effect of PROLI/NO on neointimal hyperplasia.

Authors:  Edward S M Bahnson; George E Havelka; Nathaniel C Koo; Qun Jiang; Melina R Kibbe
Journal:  J Surg Res       Date:  2016-07-05       Impact factor: 2.192

6.  Targeted Nitric Oxide Delivery by Supramolecular Nanofibers for the Prevention of Restenosis After Arterial Injury.

Authors:  Edward S M Bahnson; Hussein A Kassam; Tyson J Moyer; Wulin Jiang; Courtney E Morgan; Janet M Vercammen; Qun Jiang; Megan E Flynn; Samuel I Stupp; Melina R Kibbe
Journal:  Antioxid Redox Signal       Date:  2016-01-21       Impact factor: 8.401

7.  Nitric oxide is less effective at inhibiting neointimal hyperplasia in spontaneously hypertensive rats.

Authors:  Nick D Tsihlis; Ashley K Vavra; Janet Martinez; Vanessa R Lee; Melina R Kibbe
Journal:  Nitric Oxide       Date:  2013-10-19       Impact factor: 4.427

Review 8.  Insights on Localized and Systemic Delivery of Redox-Based Therapeutics.

Authors:  Nicholas E Buglak; Elena V Batrakova; Roberto Mota; Edward S M Bahnson
Journal:  Oxid Med Cell Longev       Date:  2018-02-14       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.